These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 17252592

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
    Donne AJ, Hampson L, He XT, Day PJ, Salway F, Rothera MP, Homer JJ, Hampson IN.
    Antivir Ther; 2009; 14(7):939-52. PubMed ID: 19918098
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cidofovir treatment improves the pathology caused by the growth of human papillomavirus-positive cervical carcinoma xenografts in athymic nude mice.
    De Schutter T, Andrei G, Topalis D, Duraffour S, Mitera T, Naesens L, van den Oord J, Matthys P, Snoeck R.
    Cancer Lett; 2013 Feb 28; 329(2):137-45. PubMed ID: 23142293
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Follow-up of HPV DNA copy number in cidofovir therapy of recurrent respiratory papillomatosis.
    Major T, Sziklai I, Czeglédy J, Gáll T, Gergely L, Szarka K.
    Anticancer Res; 2008 Feb 28; 28(4B):2169-74. PubMed ID: 18751391
    [Abstract] [Full Text] [Related]

  • 11. Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks.
    Derkay C, Multi-Disciplinary Task Force on Recurrent Respiratory Papillomas.
    Int J Pediatr Otorhinolaryngol; 2005 Nov 28; 69(11):1465-7. PubMed ID: 16174538
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
    Moore JE, Garcia A, Sanyal S, Saunders S, Portnoy JE, Hu A, Sataloff RT.
    J Voice; 2013 Nov 28; 27(6):765-8. PubMed ID: 24128893
    [Abstract] [Full Text] [Related]

  • 16. Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro.
    Hostetler KY, Rought S, Aldern KA, Trahan J, Beadle JR, Corbeil J.
    Mol Cancer Ther; 2006 Jan 28; 5(1):156-9. PubMed ID: 16432174
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
    Andrei G, Snoeck R, Piette J, Delvenne P, De Clercq E.
    Oncol Res; 1998 Jan 28; 10(10):523-31. PubMed ID: 10338155
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.